These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2538111)

  • 41. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R; Goodridge D; Denyer MS
    Vet Rec; 1984 Apr; 114(15):369-74. PubMed ID: 6328728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major immunogenic proteins of phocid herpes-viruses and their relationships to proteins of canine and feline herpesviruses.
    Harder TC; Harder M; de Swart RL; Osterhaus AD; Liess B
    Vet Q; 1998 Apr; 20(2):50-5. PubMed ID: 9563160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homologous and heterologous antibody responses of mice immunized with purified feline herpesvirus type 1 and canine herpesvirus glycoproteins.
    Limcumpao JA; Horimoto T; Xuan XN; Tohya Y; Azetaka M; Takahashi E; Mikami T
    J Vet Med Sci; 1991 Jun; 53(3):423-32. PubMed ID: 1832031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of human monoclonal antibodies to rabies.
    Dorfman N; Dietzschold B; Kajiyama W; Fu ZF; Koprowski H; Notkins AL
    Hybridoma; 1994 Oct; 13(5):397-402. PubMed ID: 7860096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
    Learmonth GS; Love DN; Wellington JE; Gilkerson JR; Whalley JM
    Arch Virol; 2002 Mar; 147(3):607-15. PubMed ID: 11958459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
    Kaufman BM; Summers PL; Dubois DR; Cohen WH; Gentry MK; Timchak RL; Burke DS; Eckels KH
    Am J Trop Med Hyg; 1989 Nov; 41(5):576-80. PubMed ID: 2817214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of an antigenic site on glycoprotein 13 (gC) of equid herpesvirus type-1.
    Sinclair R; Moult BJ; Mumford JA
    Arch Virol; 1993; 129(1-4):327-36. PubMed ID: 7682404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation by self re-fusion of bovine³ × murine² heterohybridomas secreting virus-neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD.
    Levings RL; Stoll IR; Warg JV; Patterson PA; Hobbs LA; Kaeberle ML; Roth JA
    Vet Immunol Immunopathol; 2014 May; 159(1-2):58-73. PubMed ID: 24629764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic comparisons between herpesviruses isolated from fallow deer in Alberta and the viruses of infectious bovine rhinotracheitis, equine rhinopneumonitis and DN-599, a non-IBR bovine herpesvirus.
    Kinyili JH; Thorsen J
    J Wildl Dis; 1979 Apr; 15(2):339-41. PubMed ID: 225575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenic glycoproteins of infectious laryngotracheitis herpesvirus.
    York JJ; Sonza S; Fahey KJ
    Virology; 1987 Dec; 161(2):340-7. PubMed ID: 2825407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies.
    Pifat DY; Osterling MC; Smith JF
    Virology; 1988 Dec; 167(2):442-50. PubMed ID: 2462308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56K to 58K glycoprotein.
    Donis RO; Corapi W; Dubovi EJ
    J Gen Virol; 1988 Jan; 69 ( Pt 1)():77-86. PubMed ID: 2447228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Agents of equine viral encephalomyelitis: correlation of serum and cerebrospinal fluid antibodies.
    Keane DP; Little PB; Wilkie BN; Artsob H; Thorsen J
    Can J Vet Res; 1988 Apr; 52(2):229-35. PubMed ID: 2836046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Efficacy of modified live-virus equine rhinopneumonitis vaccine.
    Stear RL; Bass EP; Beckenhauer WH
    Am J Vet Res; 1976 Mar; 37(3):349-51. PubMed ID: 176909
    [No Abstract]   [Full Text] [Related]  

  • 57. Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies.
    Mathews JH; Roehrig JT
    J Immunol; 1982 Dec; 129(6):2763-7. PubMed ID: 6183343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigenic relatedness of equine herpes virus types 1 and 3.
    Gutekunst DE; Malmquist WA; Becvar CS
    Arch Virol; 1978; 56(1-2):33-45. PubMed ID: 75724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigenic and biochemical analysis of gB of herpes simplex virus type 1 and type 2 and of cross-reacting glycoproteins induced by bovine mammillitis virus and equine herpesvirus type 1.
    Snowden BW; Kinchington PR; Powell KL; Halliburton IW
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():231-47. PubMed ID: 2981966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ
    Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.